Key statistics dashboard for bioAffinity Technologies, Inc. (BIAF). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
Stock Data
| Price | $5.35 |
| Market Cap | $2M |
| Enterprise Value | $1.2M |
| Beta | -0.81 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.05 |
| Price / Book | 0.59 |
| P/S | 0.45 |
| EV/EBITDA | -0.08 |
| EV/Sales | 0.21 |
| EV/FCF | -0.11 |
| P/FCF | -0.23 |
| Earnings Yield | -814.57% |
| FCF Yield | -513.16% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -39.57% |
| EBIT Margin | -256.47% |
| EBITDA Margin | -249.47% |
| Operating Margin | -209.82% |
| Net Margin | -257.33% |
| Return on Equity | -257.27% |
| Return on Assets | -199.30% |
| Return on Invested Capital | -237.93% |
| Return on Capital Employed | -250.72% |
Financial Health
| Current Ratio | 1.44 |
| Quick Ratio | 1.41 |
| Cash Ratio | 0.91 |
| Debt / Equity | 0.38 |
| Debt / Assets | 18.83% |
| Net Debt / EBITDA | 0.07 |
| Interest Coverage | -276.15 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -10.54 |
Per-Share Data
| Revenue per share | 16.93 |
| Book Value per share | 10.82 |
| Cash per share | 6.97 |
| FCF per share | -33.00 |
| Tangible Book Value per share | 4.81 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 0 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 0.00 |
Related companies: ARTL · CARM · GTBP · LIPO · MNDR · PBM · PTIX
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of BIAF: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks